Silo Pharma EPS SILO

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Silo Pharma's earnings per share was −$5.41 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.76.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.76	n/a	−$5.41
Q1 FY26	Mar 31, 2026	−$1.80	n/a	−$7.53
Q4 FY25	Dec 31, 2025	−$1.05	n/a	−$9.18
Q3 FY25	Sep 30, 2025	−$1.80	n/a	−$13.98
Q2 FY25	Jun 30, 2025	−$2.88	n/a	−$15.48
Q1 FY25	Mar 31, 2025	−$3.45	n/a	−$17.25
Q4 FY24	Dec 31, 2024	−$5.85	n/a	−$18.00
Q3 FY24	Sep 30, 2024	−$3.30	n/a	−$18.00
Q2 FY24	Jun 30, 2024	−$4.65	n/a	−$17.85
Q1 FY24	Mar 31, 2024	−$4.20	n/a	−$18.00
Q4 FY23	Dec 31, 2023	−$5.85	n/a	−$18.15
Q3 FY23	Sep 30, 2023	−$3.15	n/a	−$20.25

Companies in Healthcare nearest Silo Pharma's size, closest first, today.

Company	EPS, 12 months	Growth
SILOSilo Pharma	−$5.41
OXBROXBRIDGE RE HOLDINGS	$0.02
EDUCEducational Development	$0.19
GTIMGood Times Restaurants	$0.21	+75% a year
MDRRMedalist Diversified	$3.84
BCGBinah Capital	$0.16
Peer median	$0.19

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.